Found: 68
Select item for more details and to access through your institution.
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1781, doi. 10.1007/s00262-010-0904-3
- By:
- Publication type:
- Article
Identification and characterization of a HER-2/ neu epitope as a potential target for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 715, doi. 10.1007/s00262-009-0791-7
- By:
- Publication type:
- Article
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 317, doi. 10.1007/s00262-008-0576-4
- By:
- Publication type:
- Article
Ii-Key/HER-2/ neu(776–790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/ neu+ tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 601, doi. 10.1007/s00262-006-0213-z
- By:
- Publication type:
- Article
Growth inhibition of breast cancer cell lines overexpressing Her2/neu by a novel internalized fully human Fab antibody fragment.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1091, doi. 10.1007/s00262-005-0100-z
- By:
- Publication type:
- Article
Fifth European progress in vaccination against cancer conference, PIVAC 5.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 7, p. 884, doi. 10.1007/s00262-005-0120-8
- By:
- Publication type:
- Article
Immunogenic HER-2/neu peptides as tumor vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 1, p. 85, doi. 10.1007/s00262-005-0692-3
- By:
- Publication type:
- Article
Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1027, doi. 10.1007/s00262-004-0541-9
- By:
- Publication type:
- Article
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 10, p. 893, doi. 10.1007/s00262-004-0523-y
- By:
- Publication type:
- Article
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 166, doi. 10.1007/s00262-003-0475-7
- By:
- Publication type:
- Article
Natural killer lymphocytes: biology, development, and function.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 3, p. 176, doi. 10.1007/s00262-003-0478-4
- By:
- Publication type:
- Article
Natural CD8<sup>+</sup> T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 771, doi. 10.1007/s00262-003-0420-9
- By:
- Publication type:
- Article
In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RI.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 513, doi. 10.1007/s00262-002-0371-6
- By:
- Publication type:
- Article
HER-2/neu-derived peptide 884–899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4<sup>+</sup> T cell clones.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 50, n. 11, p. 615, doi. 10.1007/s002620100225
- By:
- Publication type:
- Article
Synergy between interleukin-2 and prothymosin α for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 8, p. 449, doi. 10.1007/s002620000132
- By:
- Publication type:
- Article
Induction of potent CD4.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 9, p. 2031, doi. 10.1002/ijc.22936
- By:
- Publication type:
- Article
HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3.
- Published in:
- International Journal of Cancer, 2002, v. 98, n. 6, p. 864, doi. 10.1002/ijc.10251
- By:
- Publication type:
- Article
The Organization of Contemporary Biobanks for Translational Cancer Research.
- Published in:
- Onco, 2023, v. 3, n. 4, p. 205, doi. 10.3390/onco3040015
- By:
- Publication type:
- Article
Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients.
- Published in:
- Onco, 2023, v. 3, n. 3, p. 165, doi. 10.3390/onco3030012
- By:
- Publication type:
- Article
Onco : A Promising Player Amidst Oncology Journals.
- Published in:
- Onco, 2023, v. 3, n. 2, p. 125, doi. 10.3390/onco3020009
- By:
- Publication type:
- Article
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14454, doi. 10.3390/ijms241914454
- By:
- Publication type:
- Article
Frequencies of an Immunogenic HER-2/ neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5954, doi. 10.3390/ijms24065954
- By:
- Publication type:
- Article
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2760, doi. 10.3390/ijms24032760
- By:
- Publication type:
- Article
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8257, doi. 10.3390/ijms23158257
- By:
- Publication type:
- Article
The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 6, p. N.PAG, doi. 10.3892/ijo.2022.5361
- By:
- Publication type:
- Article
Reinstating endogenous antitumor immunity: The concept of therapeutic management of cancer.
- Published in:
- Forum of Clinical Oncology, 2016, v. 7, n. 1, p. 4, doi. 10.1515/fco-2016-0005
- By:
- Publication type:
- Article
Prothymosin α restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer.
- Published in:
- International Journal of Cancer, 1993, v. 53, n. 2, p. 264, doi. 10.1002/ijc.2910530216
- By:
- Publication type:
- Article
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.
- Published in:
- Current Oncology, 2023, v. 30, n. 10, p. 8902, doi. 10.3390/curroncol30100643
- By:
- Publication type:
- Article
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 391, doi. 10.1007/s10549-020-05638-x
- By:
- Publication type:
- Article
The traditional and a new version of the mouse H-2 complex.
- Published in:
- Nature, 1981, v. 291, n. 5815, p. 455, doi. 10.1038/291455a0
- By:
- Publication type:
- Article
Effect of IL-21 on NK cells derived from different umbilical cord blood populations.
- Published in:
- International Immunology, 2006, v. 18, n. 1, p. 49, doi. 10.1093/intimm/dxh348
- By:
- Publication type:
- Article
A New Era in Anticancer Peptide Vaccines.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2071, doi. 10.1002/cncr.24988
- By:
- Publication type:
- Article
Bioassay vs. immunoassay for quantification of interleukin-6 in biological fluids.
- Published in:
- 1995
- By:
- Publication type:
- journal article
The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 11, p. 1733, doi. 10.1007/s00262-019-02407-8
- By:
- Publication type:
- Article
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 10, p. 1671, doi. 10.1007/s00262-019-02327-7
- By:
- Publication type:
- Article
4th Symposium on Advances in Cancer Immunology and Immunotherapy, November 29–December 1, 2018, Athens, Greece.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 8, p. 1391, doi. 10.1007/s00262-019-02364-2
- By:
- Publication type:
- Article
T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 705, doi. 10.1007/s00262-019-02335-7
- By:
- Publication type:
- Article
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 1, p. 57, doi. 10.1007/s00262-018-2252-7
- By:
- Publication type:
- Article
2nd Symposium on Advances in Cancer Immunology and Immunotherapy, December 15-17, 2016, Athens, Greece.
- Published in:
- 2018
- By:
- Publication type:
- Report
Compromised anti-tumor responses in tumor necrosis factor-α knockout mice.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 7, p. 1957, doi. 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO;2-7
- By:
- Publication type:
- Article
Evidence for distinct epitopes on human IgG with T cell proliferative and suppressor function.
- Published in:
- European Journal of Immunology, 1986, v. 16, n. 8, p. 1013, doi. 10.1002/eji.1830160824
- By:
- Publication type:
- Article
The role of self-Ia antigens in the murine mixed lymphocyte response.
- Published in:
- European Journal of Immunology, 1986, v. 16, n. 4, p. 361, doi. 10.1002/eji.1830160408
- By:
- Publication type:
- Article
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2393, doi. 10.3390/cancers16132393
- By:
- Publication type:
- Article
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3697, doi. 10.3390/cancers15143697
- By:
- Publication type:
- Article
Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14 , 5032.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Biomarkers in the Era of Precision Oncology.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6208, doi. 10.3390/cancers14246208
- By:
- Publication type:
- Article
Combination Immunotherapy in Prostate Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Editorial